Menu
Back to Journals » Clinical Ophthalmology » Volume 14
Management Strategies of Acute Retinal Necrosis: Current Perspectives
Authors Powell B, Wang D, Llop S, Rosen RB
Received 16 April 2020
Accepted for publication 17 June 2020
Published 8 July 2020 Volume 2020:14 Pages 1931—1943
DOI https://doi.org/10.2147/OPTH.S258488
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Brittany Powell, Daniel Wang, Stephanie Llop, Richard B Rosen
Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, United States
Correspondence: Richard B Rosen
New York Eye and Ear Infirmary of Mount Sinai, 310 East 14th Street, New York, NY 10003 Tel +1 212-979-4288
Fax +1 212-979-4268
Email rrosen@nyee.edu
Abstract: Acute retinal necrosis is a rare yet devastating disease, with significant ocular morbidity. Over the past several decades, initial treatment regimens have shifted from intravenous antivirals requiring hospital admission to the routine use of oral antivirals with intravitreal antivirals for immediate local control. Given the rarity of this disease process and a lack of large-scale research trials, debate continues over recommended practice guidelines. In this paper, we review current diagnostic criteria and recommend a treatment algorithm based on available evidence.
Keywords: occlusive vasculitis, medical management, posterior uveitis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.